How long does it take to take Ivonib/Tosovo to take effect? u200bu200bIs the effect obvious?

Ivosidenib/Tosovo（Ivosidenib) is an IDH1-targeted oral drug used to treat relapsed or refractory acute myeloid leukemia（AML), cholangiocarcinoma (CCA),myelodysplastic syndrome (MDS). SinceAML is a malignant and rapidly proliferating disease, the condition of patients varies greatly from person to person, and the time for Ivonib to take effect also varies from person to person. Generally speaking, patients can observe improvements in blood levels or morphological changes in bone marrow within weeks to months of starting medication, which are important indicators for evaluating the initial efficacy of the drug. Some patients may experience significant improvement in white blood cells, platelets or hemoglobin within 1 to 2 months, while some patients with more complex conditions may require a longer course of treatment to see stable effects.

The mechanism of action of Ivonib is to inhibitIDH1 mutant enzyme activity and reduce the accumulation of abnormal metabolite 2-hydroxyglutarate (2-HG), thereby restoring normal hematopoietic function and inhibiting cancer cell proliferation. This targeting effect makes it effective in IDH1 mutation-positive patients, especially in relapsed or refractory AML, where it can achieve partial remission or even long-term stabilization of the disease.

However, whether the drug effect is obvious or not depends not only on the drug itself, but also is closely related to the patient's condition, previous treatment history, concomitant medications and overall health status. Doctors will regularly evaluate the efficacy based on the patient's blood count, bone marrow examination and clinical symptoms, and adjust the dose or combine it with other treatments if necessary to obtain the best effect. At the same time, patients should maintain regular medication and avoid missing doses or stopping medication at will to ensure stable efficacy.

In general, the effects of ivosidenib usually begin to show within weeks to months, but the effects vary from person to person. Through regular monitoring and individualized adjustments, the advantages of drugs can be maximized and provide stable and sustainable treatment options for AML patients.

Reference: https://www.tibsovo.com/